Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

2 terminated/withdrawn out of 16 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

Phase 2
6(46.2%)
N/A
3(23.1%)
Phase 1
3(23.1%)
Early Phase 1
1(7.7%)
13Total
Phase 2(6)
N/A(3)
Phase 1(3)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT05969496Phase 2Recruiting

Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

Role: collaborator

NCT04042935Phase 1Completed

Alpha Lipoic Acid to Decrease Pain and Side Effects in Concurrent Treatment of HNSCC

Role: collaborator

NCT07434817Not ApplicableNot Yet Recruiting

Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment

Role: collaborator

NCT07292298Phase 2Recruiting

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

Role: collaborator

NCT07125183Phase 2Recruiting

Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

Role: collaborator

NCT03900793Phase 1Recruiting

Losartan + Sunitinib in Treatment of Osteosarcoma

Role: collaborator

NCT04028167Phase 2Active Not Recruiting

Induction FLOT With CROSS CRT for Esophageal Cancer

Role: collaborator

NCT03734653Early Phase 1Completed

Testosterone Therapy in Castration Resistant Prostate Cancer

Role: collaborator

NCT03409016Active Not Recruiting

Biomarkers of Immune-Related Toxicity

Role: collaborator

NCT04533165Not ApplicableActive Not Recruiting

Virtual Exercise Program to Reduce Cancer Related Fatigue

Role: collaborator

NCT03958565Recruiting

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.

Role: collaborator

NCT03087903Not ApplicableCompleted

A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA

Role: collaborator

NCT05520294Active Not Recruiting

Evaluating the Effects of Cannabis Use and Circulating Cannabinoids on Tumor Infiltrating Lymphocytes in Malignant Melanoma

Role: collaborator

NCT04541407Phase 1Completed

Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease

Role: collaborator

NCT05233696Phase 2Withdrawn

Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC

Role: collaborator

NCT04001101Phase 2Withdrawn

Anti-PD-1 +/- RT for MSI-H Solid Tumors

Role: collaborator

All 16 trials loaded